Shuji Maruyama

423 total citations
15 papers, 357 citations indexed

About

Shuji Maruyama is a scholar working on Urology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Shuji Maruyama has authored 15 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Urology, 5 papers in Cellular and Molecular Neuroscience and 4 papers in Molecular Biology. Recurrent topics in Shuji Maruyama's work include Urinary Bladder and Prostate Research (9 papers), Neuropeptides and Animal Physiology (5 papers) and Receptor Mechanisms and Signaling (4 papers). Shuji Maruyama is often cited by papers focused on Urinary Bladder and Prostate Research (9 papers), Neuropeptides and Animal Physiology (5 papers) and Receptor Mechanisms and Signaling (4 papers). Shuji Maruyama collaborates with scholars based in Japan, Sweden and Czechia. Shuji Maruyama's co-authors include Shizuo Yamada, Tomomi Oki, Shinya Uchida, Hideo Tsukada, Yoshihiko Ito, Yuki Ohmori, Dai Fukumoto, Keizo Umegaki, Hiroshi Yamada and Akira Yoshida and has published in prestigious journals such as NeuroImage, The Journal of Urology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Shuji Maruyama

15 papers receiving 345 citations

Peers

Countries citing papers authored by Shuji Maruyama

Since Specialization

Citations

This map shows the geographic impact of Shuji Maruyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuji Maruyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuji Maruyama more than expected).

Fields of papers citing papers by Shuji Maruyama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuji Maruyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuji Maruyama. The network helps show where Shuji Maruyama may publish in the future.

Co-authorship network of co-authors of Shuji Maruyama

This figure shows the co-authorship network connecting the top 25 collaborators of Shuji Maruyama. A scholar is included among the top collaborators of Shuji Maruyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuji Maruyama. Shuji Maruyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Suitability of chemiluminescent enzyme immunoassay for the measurement of blood tacrolimus concentrations in rheumatoid arthritis 2011 ·Clinical Biochemistry ·(unknown), Shuji Maruyama, Yasuaki Mino, Takafumi Naito, Junichi Kawakami	10
2	Effect of oxybutynin and imidafenacin on central muscarinic receptor occupancy and cognitive function: A monkey PET study with [11C](+)3-MPB 2011 ·NeuroImage ·Shigeyuki Yamamoto, Shuji Maruyama, Yoshihiko Ito, (unknown), Shingo Nishiyama, Hiroyuki Ohba, Shizuo Yamada, Hideo Tsukada	22
3	Noninvasive evaluation of brain muscarinic receptor occupancy of oxybutynin, darifenacin and imidafenacin in rats by positron emission tomography 2010 ·Life Sciences ·Akira Yoshida, Shuji Maruyama, Dai Fukumoto, Hideo Tsukada, Yoshihiko Ito, Shizuo Yamada	28
4	The Forefront for Novel Therapeutic Agents Based on the Pathophysiology of Lower Urinary Tract Dysfunction: Bladder Selectivity Based on In Vivo Drug–Receptor Binding Characteristics of Antimuscarinic Agents for Treatment of Overactive Bladder 2010 ·Journal of Pharmacological Sciences ·Akira Yoshida, (unknown), Shuji Maruyama, Yoshihiko Ito, Yuko Taki, Shizuo Yamada	25
5	In Vivo Quantitative Autoradiographic Analysis of Brain Muscarinic Receptor Occupancy by Antimuscarinic Agents for Overactive Bladder Treatment 2008 ·Journal of Pharmacology and Experimental Therapeutics ·Shuji Maruyama, Hideo Tsukada, Shingo Nishiyama, Takeharu Kakiuchi, Dai Fukumoto, Naoto Oku, Shizuo Yamada	39
6	In vivo characterization of muscarinic receptors in peripheral tissues: evaluation of bladder selectivity of anticholinergic agents to treat overactive bladder 2007 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Shuji Maruyama, (unknown), Kazuhiro Suzuki, Shizuo Yamada	6
7	Urodynamics and bladder muscarinic receptors in rats with cerebral infarction and bladder outlet obstruction 2007 ·Neuroscience Letters ·Shuji Maruyama, (unknown), (unknown), Tomomi Oki, Yukiko Noguchi, Masashi Ukai, Hironori Yuyama, Akiyoshi Ohtake, Masanori Suzuki, Masao Sasamata, Shizuo Yamada	12
8	Effects of Ginkgo Biloba Extract on Pharmacokinetics and Pharmacodynamics of Tolbutamide and Midazolam in Healthy Volunteers 2006 ·The Journal of Clinical Pharmacology ·Shinya Uchida, Hiroshi Yamada, Xiao Dong Li, Shuji Maruyama, Yuki Ohmori, Tomomi Oki, Hiroshi Watanabe, Keizo Umegaki, Kyoichi Ohashi, Shizuo Yamada	90
9	In vivo demonstration of M3 muscarinic receptor subtype selectivity of darifenacin in mice 2006 ·Life Sciences ·Shizuo Yamada, Shuji Maruyama, (unknown), Shinya Uchida, Tomomi Oki	26
10	Human Muscarinic Receptor Binding Characteristics of Antimuscarinic Agents to Treat Overactive Bladder 2006 ·The Journal of Urology ·Shuji Maruyama, Tomomi Oki, Atsushi Otsuka, Hitoshi Shinbo, Seiichiro Ozono, Shinji Kageyama, (unknown), Isao Araki, Masayuki Takeda, Keisuke Masuyama, Shizuo Yamada	5
11	Characterization of muscarinic receptor binding and inhibition of salivation after oral administration of tolterodine in mice 2005 ·European Journal of Pharmacology ·Tomomi Oki, Shuji Maruyama, (unknown), Henry I. Yamamura, Shizuo Yamada	21
12	Human Muscarinic Receptor Binding Characteristics of Antimuscarinic Agents to Treat Overactive Bladder 2005 ·The Journal of Urology ·Shuji Maruyama, Tomomi Oki, Atsushi Otsuka, Hitoshi Shinbo, Seiichiro Ozono, Shinji Kageyama, (unknown), Isao Araki, Masayuki Takeda, Keisuke Masuyama, Shizuo Yamada	47
13	Pharmacological effects and lung-binding characteristics of a novel VIP analogue, [R15, 20, 21, L17]-VIP-GRR (IK312532) 2004 ·Regulatory Peptides ·Yuki Ohmori, Shuji Maruyama, Ryohei Kimura, Satomi Onoue, Asami Matsumoto, Kosuke Endo, Toshihiko Iwanaga, Kazuhisa Kashimoto, Shizuo Yamada	16
14	EFFECTS OF GINKGO BILOBA EXTRACT ON PHARMACOKINETICS AND PHARMACODYNAMICS OF TOLBUTAMIDE AND MIDAZOLAM IN HEALTHY VOLUNTEERS 2004 ·Medical Entomology and Zoology ·Shuji Maruyama, Yuki Ohmori, Tomomi Oki, Xiao Dong Li, Shinya Uchida, Hiroshi Yamada, Hiroshi Watanabe, Keizo Umegaki, Kyoichi Ohashi, Shizuo Yamada	1
15	Electron Spin Resonance in Triangular Antiferromagnets 2003 ·Journal of the Physical Society of Japan ·Hidekazu Tanaka, Toshio Ono, Shuji Maruyama, S. Teraoka, Kazukiyo Nagata, Hitoshi Ohta, Susumu Okubo, Shojiro Kimura, Takashi Kambe, Hiroyuki Nojiri, M. Motokawa	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact